Mediclin AG/ DE0006595101 /
| - - | Chg. - | Volume | Bid- | Ask5:07:13 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 4.22EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 114 mill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.23 EUR | -215.00% |
| EPS Diluted: | - EUR | - |
| Revenues per Share: | 15.37 EUR | 3.60% |
| Book Value per Share: | 4.12 EUR | -6.35% |
| Cash Flow per Share: | 1.64 EUR | 125.18% |
| Dividend per Share: | - EUR | - |
| Total | in mill. | |
| Revenues: | 730.07 EUR | 3.60% |
| Net Income: | -10.78 EUR | -214.15% |
| Operating Cash Flow: | 78.00 EUR | - |
| Cash and Cash Equivalents: | 115.29 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 0.16 | 0.16 |
| P/BV ratio: | 0.58 | 0.61 |
| P/CF Ratio: | 1.46 | 1.53 |
| PEG: | 0.05 | - |
| Earnings Yield: | -9.58% | -9.13% |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 114 mill. EUR | 119.7 mill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | 16,248.5747 EUR | 17,061.0034 EUR |
| Shares Outstanding: | 47.5 mill. | |
Profitability
| Gross Profit Margin: | 94.98% |
| EBIT Margin: | 1.74% |
| Net Profit Margin: | -1.48% |
| Return on Equity: | -5.50% |
| Return on Assets: | -1.22% |
Financial Strength
| Liquidity I / Cash Ratio: | 67.32% |
| Liquidity II / Quick Ratio: | 114.97% |
| Liquidity III / Current Ratio: | 175.09% |
| Debt / Equity Ratio: | 349.43% |
| Dynam. Debt / Equity Ratio: | 877.66% |
Efficiency
| Employees: | 7,016 |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | 104,058.01 EUR |
| Net Income / Employee: | -1,535.92 EUR |
| Total Assets / Employee: | 125,499.00 EUR |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | IFRS |
| Currency: | EUR |
